Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Clinikally
AddedMar 20, 2024
UpdatedJun 18, 2026
Clinikally

Clinikally

Seed

India's top telemedicine for dermatology, offering personalized online consultations and care products.

HQ
Gurgaon, Haryana, IN
Founded
2021
Accelerator
Y Combinator logoY CombinatorS22
Overview
Compare
Fundraising
Employees
Website

Clinikally, founded with the mission to revolutionize dermatology care in India, aims to provide accessible, science-based, and personalized healthcare solutions. The platform offers telehealth services, AI-powered treatment plans, and prescription-grade products tailored to individual needs. Clinikally focuses on dermatology, nutrition, and wellness, leveraging patient data such as prescription history, medical parameters, and lifestyle factors to deliver customized care.

Notable affiliated individuals and investors include experts in dermatology and digital health sectors. Clinikally has achieved significant milestones in expanding telemedicine access across India and integrating AI into treatment planning. Its impact is evident in the improved dermatological health outcomes for numerous patients, positioning it as a leading digital health destination in its market.

Clinikally - Similar Companies

DocVita logo

DocVita

docvita.com

My NextDerma logo

My NextDerma

mynextderma.com

CureSkin logo

CureSkin

cureskin.com

Klarity logo

Klarity

helloklarity.com

Dr.Online logo

Dr.Online

dronline.com

Direct Dermatology logo

Direct Dermatology

directderm.com

FirstDerm logo

FirstDerm

firstderm.com

Heally logo

Heally

getheally.com

Alpha Medical logo

Alpha Medical

helloalpha.com

Docty logo

Docty

docty.ai

Clinetic logo

Clinetic

clinetic.com

Curology logo

Curology

curology.com

Doctor On Demand logo

Doctor On Demand

doctorondemand.com

SteadyMD logo

SteadyMD

steadymd.com

Distinct Dermatology logo

Distinct Dermatology

Clinikally - Quick Facts

Who are Clinikally's competitors?

Companies similar to Clinikally include DocVita, My NextDerma, CureSkin and Klarity.

When was Clinikally founded?

Clinikally was founded in 2021.

Where is Clinikally's headquarters located?

Clinikally's headquarters is located in Gurgaon, Haryana, IN.

When was Clinikally's last funding round?

Clinikally's most recent funding round was for $2.6M (USD) in September 2023.

How much has Clinikally raised to-date?

As of Sep 29, 2023, Clinikally has raised a total of $3.2M (USD).

How many employees does Clinikally have?

Clinikally has 48 employees as of Apr 29, 2024.

Clinikally - Classification

Ownership
  • Venture Capital
Technology
  • AI
Geographic Exposure
  • India
Model
  • Platform
Revenue
  • Recurring
  • Transactional
Customer
  • Consumers
Main Product
  • Skincare
  • Telemedicine
Tags
  • eCommerce
  • Healthtech
  • SaaS
NAICS
  • 456000Health and Personal Care Retailers
  • 450000Retail Trade
  • 456100Health and Personal Care Retailers
  • 456110Pharmacies and Drug Retailers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 4 more industry codes
NAICS
  • 440000Retail Trade
  • 620000Health Care and Social Assistance
SIC
  • 5900Miscellaneous Retail
  • 5910Drug Stores And Proprietary Stores